Inspire Medical Systems Gross Margin 2017-2025 | INSP
Current and historical gross margin for Inspire Medical Systems (INSP) over the last 10 years. The current gross profit margin for Inspire Medical Systems as of June 30, 2025 is %.
| Inspire Medical Systems Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-06-30 | $0.86B | $0.73B | 84.55% |
| 2025-03-31 | $0.84B | $0.71B | 84.76% |
| 2024-12-31 | $0.80B | $0.68B | 84.68% |
| 2024-09-30 | $0.76B | $0.64B | 84.66% |
| 2024-06-30 | $0.71B | $0.60B | 84.70% |
| 2024-03-31 | $0.66B | $0.56B | 84.57% |
| 2023-12-31 | $0.63B | $0.53B | 84.48% |
| 2023-09-30 | $0.57B | $0.48B | 84.21% |
| 2023-06-30 | $0.53B | $0.44B | 83.65% |
| 2023-03-31 | $0.47B | $0.39B | 83.69% |
| 2022-12-31 | $0.41B | $0.34B | 83.78% |
| 2022-09-30 | $0.35B | $0.29B | 84.15% |
| 2022-06-30 | $0.30B | $0.26B | 85.33% |
| 2022-03-31 | $0.26B | $0.22B | 85.50% |
| 2021-12-31 | $0.23B | $0.20B | 85.41% |
| 2021-09-30 | $0.20B | $0.17B | 85.07% |
| 2021-06-30 | $0.18B | $0.15B | 85.14% |
| 2021-03-31 | $0.13B | $0.11B | 85.07% |
| 2020-12-31 | $0.12B | $0.10B | 85.22% |
| 2020-09-30 | $0.10B | $0.08B | 85.42% |
| 2020-06-30 | $0.08B | $0.07B | 83.95% |
| 2020-03-31 | $0.09B | $0.07B | 83.91% |
| 2019-12-31 | $0.08B | $0.07B | 82.93% |
| 2019-09-30 | $0.07B | $0.06B | 80.56% |
| 2019-06-30 | $0.06B | $0.05B | 81.25% |
| 2019-03-31 | $0.06B | $0.05B | 80.70% |
| 2018-12-31 | $0.05B | $0.04B | 80.39% |
| 2018-09-30 | $0.04B | $0.04B | 81.82% |
| 2018-06-30 | $0.04B | $0.03B | 81.58% |
| 2018-03-31 | $0.03B | $0.03B | 81.82% |
| 2017-12-31 | $0.03B | $0.02B | 82.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.705B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $44.502B | 54.47 |
| Doximity (DOCS) | United States | $12.809B | 56.99 |
| Tempus AI (TEM) | United States | $12.797B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.972B | 81.70 |
| IRhythm Technologies (IRTC) | United States | $5.509B | 0.00 |
| Hinge Health (HNGE) | United States | $4.528B | 0.00 |
| Privia Health (PRVA) | United States | $2.677B | 198.27 |
| Heartflow (HTFL) | $2.609B | 0.00 | |
| Phreesia (PHR) | United States | $1.937B | 0.00 |
| 10x Genomics (TXG) | United States | $1.778B | 0.00 |
| Enovis (ENOV) | United States | $1.749B | 9.24 |
| Omnicell (OMCL) | United States | $1.529B | 29.45 |
| Schrodinger (SDGR) | United States | $1.454B | 0.00 |
| Azenta (AZTA) | United States | $1.372B | 59.84 |
| Clover Health Investments (CLOV) | United States | $1.348B | 0.00 |
| Claritev (CTEV) | United States | $1.174B | 0.00 |
| Evolent Health (EVH) | United States | $1.133B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.674B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Standard BioTools (LAB) | United States | $0.493B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.410B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.60 |
| Health Catalyst (HCAT) | United States | $0.257B | 0.00 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.164B | 0.00 |
| CareCloud (CCLD) | United States | $0.160B | 7.27 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.082B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |